User menu

Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.

Bibliographic reference Rahier, Jean-François ; Druez, Anne ; Faugeras, Laurence ; Martinet, Jean-Paul ; GÉHÉNOT, Myriam ; et. al. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.. In: Clinical Epigenetics, Vol. 9, no.1, p. 53 (2017)
Permanent URL http://hdl.handle.net/2078.1/185414
  1. Ferlay Jacques, Soerjomataram Isabelle, Dikshit Rajesh, Eser Sultan, Mathers Colin, Rebelo Marise, Parkin Donald Maxwell, Forman David, Bray Freddie, Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 : Globocan 2012, 10.1002/ijc.29210
  2. DeSantis CE, Chieh Lin C, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252–71.
  3. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.
  4. Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology. 2014;146(3):709–17.
  5. Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10):1637-49.
  6. Winawer SJ, Fischer SE, Levin B. Evidence-based, reality-driven colorectal cancer screening guidelines: the critical relationship of adherence to effectiveness. JAMA. 2016;315(19):2065–6.
  7. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383:1490–502.
  8. Kedrin D, Gala MK. Genetics of the serrated pathway to colorectal cancer. Clin Transl Gastroenterol. 2015;6(4):84.
  9. Füllgrabe J, Kavanagh E, Joseph B. Histone onco-modifications. Oncogene. 2011;30(31):3391–403.
  10. HOLDENRIEDER STEFAN, STIEBER PETRA, BODENMÜLLER HEINZ, BUSCH MARTIN, PAWEL JOACHIM, SCHALHORN ANDREAS, NAGEL DOROTHEA, SEIDEL DIETRICH, Circulating Nucleosomes in Serum, 10.1111/j.1749-6632.2001.tb03869.x
  11. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426–37.
  12. Elshimali Yahya, Khaddour Husseina, Sarkissyan Marianna, Wu Yanyuan, Vadgama Jaydutt, The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients, 10.3390/ijms140918925
  13. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5.
  14. Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6):623–5.
  15. Summers T, Langan RC, Nissan A, et al. Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection. J Cancer. 2013;4(3):210–6.
  16. Jin H, Ma Y, Shen Q, et al. Circulating methylated DNA as biomarkers for cancer detection. In: Dricu A, editor. Methylation - from DNA, RNA and Histones to Diseases and Treatment. Rijeka: InTech; 2013. p. 137–52.
  17. deVos T, Tetzner R, Model F, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55(7):1337–46.
  18. Holdenrieder S, Dharuman Y, Standop J, et al. Novel serum nucleosomics biomarkers for the detection of colorectal cancer. Anticancer Res. 2014;34(5):2357–62.
  19. Bauden M, Pamart D, Ansari D, et al. Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer. Clin Epigenetics. 2015;7:106.
  20. Gezer U, Yörüker EE, Keskin M, Kulle CB, Dharuman Y, Holdenrieder S. Histone methylation marks on circulating nucleosomes as novel blood-based biomarker in colorectal cancer. Int J Mol Sci. 2015;16(12):29654–62.
  21. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/ . R Found Stat Comput Vienna, Austria. 2015:2015.
  22. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313–27.